Investing
Opening Bell Analysts Research Calls for Tuesday, March 7
March 7, 2023 9:38 am
This report was sent to Briefing.com subscribers earlier today.
Research calls posted earlier this morning are available here.
Upgrades:
> Carrols Restaurant Group (TAST) upgraded to Buy from Hold at Craig Hallum; tgt raised to $4
> Delta Air Lines (DAL) upgraded to Outperform from In-line at Evercore ISI; tgt raised to $47
> DraftKings (DKNG) upgraded to Buy from Hold at Argus; tgt $22
> Esperion Therapeutics (ESPR) upgraded to Neutral from Underperform at Credit Suisse; tgt raised to $7
> Kimbell Royalty Partners (KRP) upgraded to Overweight from Sector Weight at KeyBanc Capital Markets; tgt $21
> NuStar Energy (NS) upgraded to Buy from Hold at Stifel; tgt lowered to $19.50
> United Airlines (UAL) upgraded to Outperform from Underperform at Exane BNP Paribas; tgt $70
Downgrades:
> Black Stone Minerals (BSM) downgraded to Sector Weight from Overweight at KeyBanc Capital Markets
> CareDx (CDNA) downgraded to Equal-Weight from Overweight at Stephens; tgt lowered to $9
> Office Properties Income Trust (OPI) downgraded to Underperform from Sector Perform at RBC Capital Mkts; tgt lowered to $14
> Ovintiv (OVV) downgraded to Market Perform from Outperform at BMO Capital Markets; tgt lowered to $51
> Rolls Royce PLC (RYCEY) downgraded to Equal Weight from Overweight at Barclays
> Trimble (TRMB) downgraded to Sell from Neutral at Northcoast; tgt $40
Others:
> Allakos (ALLK) initiated with an Overweight at Piper Sandler; tgt $22
> Cisco (CSCO) initiated with a Neutral at Goldman
> CRISPR Therapeutics (CRSP) initiated with a Neutral at Robert W. Baird; tgt $46
> Enlight Renewable Energy Ltd. (ENLT) initiated with an Outperform at Credit Suisse; tgt $22
> Enlight Renewable Energy Ltd. (ENLT) initiated with an Outperform at Wolfe Research; tgt $21
> Enlight Renewable Energy Ltd. (ENLT) initiated with an Overweight at Barclays; tgt $21
> Enlight Renewable Energy Ltd. (ENLT) initiated with an Overweight at JP Morgan; tgt $23
> F5 Networks (FFIV) initiated with a Neutral at Goldman
> Fresenius Medical (FMS) initiated with a Mkt Perform at Bernstein
> Lexicon Pharma (LXRX) initiated with a Hold at Jefferies; tgt $3
> Mineralys Therapeutics (MLYS) initiated with a Buy at BofA Securities; tgt $39
> Mineralys Therapeutics (MLYS) initiated with a Buy at Guggenheim; tgt $32
> Mineralys Therapeutics (MLYS) initiated with a Buy at Stifel; tgt $45
> Mineralys Therapeutics (MLYS) initiated with an Outperform at Credit Suisse; tgt $40
> Mineralys Therapeutics (MLYS) initiated with an Outperform at Evercore ISI
> Mineralys Therapeutics (MLYS) initiated with an Overweight at Wells Fargo; tgt $27
> Perrigo (PRGO)initiated with a Buy at Canaccord Genuity; tgt $49
> Qualys (QLYS) initiated with a Buy at Westpark Capital; tgt $170
> Rentokil (RTOKY) resumed with an Overweight at Barclays
> Scor (SCRYY) resumed with an Equal Weight at Barclays
> Upstart (UPST) initiated with a Sell at Compass Point; tgt $6
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Editors' Picks
